Filing Details
- Accession Number:
- 0001209191-18-057820
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-11-08 18:47:40
- Reporting Period:
- 2018-11-08
- Accepted Time:
- 2018-11-08 18:47:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1515673 | Ultragenyx Pharmaceutical Inc. | RARE | Pharmaceutical Preparations (2834) | 272546083 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1598426 | William Aliski | C/O Ultragenyx Pharmaceutical Inc. 60 Leveroni Court Novato CA 94949 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-11-08 | 6,000 | $55.67 | 96,350 | No | 4 | S | Indirect | By trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By trust |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 72,610 | Direct |
Footnotes
- The sale reported on this Form 4 was effected pursuant to a trading plan adopted by the Reporting Person's trust pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- These shares are held in a trust for the benefit of the reporting person's spouse and children. The reporting person's spouse and nephew are trustees of the trust.
Billionaire Hedge Funds
